Doxofylline active pharmaceutical ingredient supplier

Doxofylline active pharmaceutical ingredient supplier About

Doxofylline is a derivative used for the treatment and maintenance of chronic obstructive pulmonary disease (COPD) bronchial asthma and airway spasms. It functions as a bronchodilator by relaxing the smooth muscles of the airways and reducing airway inflammation often referred to as novofylline. Compared to theophylline it provides similar efficacy with significantly fewer cardiovascular and central nervous system side effects.

A Reliable Solution for Respiratory Medications

Doxofylline is utilized as an active ingredient in effective pharmaceutical treatments targeting asthma and chronic obstructive pulmonary disease (COPD). With its optimal purity (>99% by HPLC) and stability, it ensures consistent performance and reliable results in patient therapies.


Product Stability and Storage Recommendations

This API is non-hygroscopic and stable at room temperature, guaranteeing quality retention during transport and storage. The product's recommended packaging-double LDPE bags within HDPE drums-offers enhanced protection against contamination, maintaining its pharmaceutical-grade integrity throughout its shelf life.


Focused on Compliance and Quality

Our Doxofylline meets stringent quality criteria: Loss on Drying 0.5%, heavy metals 20 ppm, chlorides 0.05%, and complies fully with pharmacopoeia-mandated microbial limits. With single and total impurities controlled at <0.1% and <0.5% respectively, it is produced to meet the most demanding industry and regulatory standards.